Informed Consent clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for

  • AI-Driven Consent Simplification Study

    open to eligible people ages 18 years and up

    The overarching goal of this pilot is to explore how generative artificial intelligence (genAI) can be used to improve the accessibility and understandability of informed consent materials in clinical research. The study will test the extent to which informed consent text can be improved by large language models (LLM; specifically, ChatGPT and NotebookLM) along with other AI tools (specifically, ElevenLabs) through qualitative and quantitative analyses. Simplifying such forms using genAI may facilitate better comprehension, ensuring truly informed consent. Improving informed consent form (ICF) comprehension can lead to more informed and willing participation in clinical studies. This improved understanding may result in higher enrollment rates, better subject retention, and more accurate data collection as individuals will have a clearer understanding of study procedures and risks.

    at UCLA

  • Supporting Just-In-Time Consent for Prenatal Screening: The INFORM Study

    Sorry, not yet accepting patients

    This clinical trial is about prenatal genetic screening. It will test an intervention to help people make decisions about screening. The intervention is a short set of information cards about screening. This intervention is for pregnant participants. They will use the intervention on their mobile phone before they see their doctor. The study has one main question: - Do participants who use the intervention feel more confident when they make a decision about screening? Researchers will compare participants who use the intervention to participants who do not. All participants will have their usual care when they visit their doctor. What will participants do? - Participants must be pregnant. They will sign up for the study before their first doctor's visit for their pregnancy. This is the visit where their doctor usually talks with them about screening. - Some participants will use the intervention before their first doctor's visit. Other participants will not use it. - All participants will talk with a researcher on the phone after their first doctor's visit. - Participants who use the intervention will answer a short survey on their phone. - A few participants who use the intervention will talk with a researcher a second time on the phone.

    at UCSF

Our lead scientists for Informed Consent research studies include .

Last updated: